January 3, 2022
CTSW Represents Pharmaceutical Company Benuvia Holdings in M&A Transactions

CTSW represented Benuvia Holdings, LLC with the sale of Benuvia Manufacturing Inc., Benuvia Manufacturing, LLC, Benuvia Therapeutics LLC and Benuvia Therapeutics IP LLC. Benuvia Therapeutics markets Syndros, a U.S. FDA-approved cannabinoid drug and has a pipeline of clinical stage product candidates focused on rare diseases. The transactions are the latest in CTSW’s long history of […]

read more
December 6, 2021
CTSW Wins Dismissal of $4 Million Action Against Seafood Investor Client

CTSW prevailed in a motion to dismiss a $4 million action against a client, an investor in a shrimp business. The action included allegations of fraud and unjust enrichment based on the investor’s relationship to an estranged wife and a business partner running the business. The court agreed with CTSW’s argument that the fraud allegations, […]

read more
October 4, 2021
Jerry Cohen on Panel Discussing Healthtech Investments

CTSW’s Jerry Cohen was on a panel hosted by the Yale Alumni Health Network and Global Blockchain Business Council on challenges and opportunities in healthtech investments. The panel took place on September 28. A recording of the one-hour discussion is available here. The firm works extensively with healthtech executives, entrepreneurs, and investors.

read more